Geojit Strategist Recommends Buying Avalon & Healthcare Global Stocks

Anand James, Chief Market Strategist at Geojit Investments Ltd., has issued buy recommendations for two prominent stocks: Avalon Technologies and Healthcare Global Enterprises. Both scrips show promising technical setups indicating potential for significant upside.

Avalon Technologies Eyes ₹2,200 Target

Avalon Technologies, currently trading at ₹1,965, has been recommended for a buy. This follows a clear breakout above a crucial horizontal resistance level, completing a double-bottom formation.

The technical analysis points to a potential trend reversal and a continuation of its broader upward trajectory. Strong price expansion coupled with a surge in volume confirms renewed buying interest.

• LTP: ₹1,965
• Recommendation: Buy
• Target Price: ₹2,200
• Stop Loss: ₹1,700

Momentum indicators remain favorable, with the MACD histogram entering positive territory and signaling a reversal. The stock’s position above its key moving averages further reinforces this positive technical structure.

Healthcare Global Breaks Out Towards ₹760

Healthcare Global Enterprises, with a Last Traded Price (LTP) of ₹715, also received a buy rating. The stock registered a strong breakout from a prolonged parallel consolidation range.

This move was backed by a significant surge in volumes, highlighting robust buying interest from participants. A bullish Marubozu candle on the daily chart indicates decisive control by buyers.

• LTP: ₹715
• Recommendation: Buy
• Target Price: ₹760
• Stop Loss: ₹688

The MACD shows a bullish signal-line crossover and histogram expansion, suggesting strengthening upside momentum. HCG has successfully reclaimed key resistance levels, now trading above its recent range highs.

While the Relative Strength Index (RSI) is in a higher zone, it aligns with strong trending stocks and does not yet signal an imminent reversal. The bullish structure remains intact as long as HCG holds above the ₹700 breakout zone.

Both Avalon Technologies and Healthcare Global Enterprises are anticipated to extend their gains in the coming weeks, with analysts closely monitoring their respective breakout levels.